Valutazione della qualità della vita nel carcinoma pancreatico: risultati di uno studio multicentrico europeo.

Translated title of the contribution: Quality of life assessment in pancreatic carcinoma: results of an European multicentric study

C. Bassi, C. Johnson, D. Fitzsimmons, M. Falconi, G. Butturini, C. Contro, I. Frigerio, P. Pederzoli

Research output: Contribution to journalArticle

Abstract

Quality of life (Qol) assessment is a mandatory endpoint of cancer clinical trials. Little research has been conducted on pancreatic cancer (Pc) and no disease specific Qol questionnaire exists. We report on the development of the European Organization for Research and Treatment of Cancer (EORTC) Pc Qol module to supplement the core cancer module (QLQ-C30). Literature research and qualitative interviews with 6 specialists and 34 patients in the UK were followed by construction of a questionnaire, a peer review by international specialists and EORTC. Administration of the QLQ-C 30, a provisional Pc module and a qualitative debriefing interview was performed on 78 patients in 8 countries stratified into groups by disease stage and treatment intention. Pretesting identified that 23/26 questions had an adequate internal reliability (Cronbach's alpha > 0.7) and construct validity (Pearson's r 0.4-0.6). The median time of completion was 12 mins. Qualitative analysis indicates that the module is easy to complete and cross culturally applicable. The EORTC QLO-PAN 26 includes 26 items covering symptoms, body image, sexuality and the emotional and social consequences of Pc. It is intended for use in patients undergoing clinical trials for pancreatic cancer including surgery, chemotherapy and radiotherapy and will allow the detection of small but clinically meaningful differences in clinical trials for Pc.

Original languageItalian
Pages (from-to)359-366
Number of pages8
JournalChirurgia Italiana
Volume51
Issue number5
Publication statusPublished - Sep 1999

Fingerprint

Pancreatic Neoplasms
Quality of Life
Clinical Trials
Organizations
Neoplasms
Research
Interviews
Peer Review
Qualitative Research
Body Image
Sexuality
Therapeutics
Pancreatic Carcinoma
Radiotherapy
Drug Therapy

ASJC Scopus subject areas

  • Surgery

Cite this

Bassi, C., Johnson, C., Fitzsimmons, D., Falconi, M., Butturini, G., Contro, C., ... Pederzoli, P. (1999). Valutazione della qualità della vita nel carcinoma pancreatico: risultati di uno studio multicentrico europeo. Chirurgia Italiana, 51(5), 359-366.

Valutazione della qualità della vita nel carcinoma pancreatico : risultati di uno studio multicentrico europeo. / Bassi, C.; Johnson, C.; Fitzsimmons, D.; Falconi, M.; Butturini, G.; Contro, C.; Frigerio, I.; Pederzoli, P.

In: Chirurgia Italiana, Vol. 51, No. 5, 09.1999, p. 359-366.

Research output: Contribution to journalArticle

Bassi, C, Johnson, C, Fitzsimmons, D, Falconi, M, Butturini, G, Contro, C, Frigerio, I & Pederzoli, P 1999, 'Valutazione della qualità della vita nel carcinoma pancreatico: risultati di uno studio multicentrico europeo.', Chirurgia Italiana, vol. 51, no. 5, pp. 359-366.
Bassi, C. ; Johnson, C. ; Fitzsimmons, D. ; Falconi, M. ; Butturini, G. ; Contro, C. ; Frigerio, I. ; Pederzoli, P. / Valutazione della qualità della vita nel carcinoma pancreatico : risultati di uno studio multicentrico europeo. In: Chirurgia Italiana. 1999 ; Vol. 51, No. 5. pp. 359-366.
@article{b6721d35ec794d3b95e8bb848472d033,
title = "Valutazione della qualit{\`a} della vita nel carcinoma pancreatico: risultati di uno studio multicentrico europeo.",
abstract = "Quality of life (Qol) assessment is a mandatory endpoint of cancer clinical trials. Little research has been conducted on pancreatic cancer (Pc) and no disease specific Qol questionnaire exists. We report on the development of the European Organization for Research and Treatment of Cancer (EORTC) Pc Qol module to supplement the core cancer module (QLQ-C30). Literature research and qualitative interviews with 6 specialists and 34 patients in the UK were followed by construction of a questionnaire, a peer review by international specialists and EORTC. Administration of the QLQ-C 30, a provisional Pc module and a qualitative debriefing interview was performed on 78 patients in 8 countries stratified into groups by disease stage and treatment intention. Pretesting identified that 23/26 questions had an adequate internal reliability (Cronbach's alpha > 0.7) and construct validity (Pearson's r 0.4-0.6). The median time of completion was 12 mins. Qualitative analysis indicates that the module is easy to complete and cross culturally applicable. The EORTC QLO-PAN 26 includes 26 items covering symptoms, body image, sexuality and the emotional and social consequences of Pc. It is intended for use in patients undergoing clinical trials for pancreatic cancer including surgery, chemotherapy and radiotherapy and will allow the detection of small but clinically meaningful differences in clinical trials for Pc.",
author = "C. Bassi and C. Johnson and D. Fitzsimmons and M. Falconi and G. Butturini and C. Contro and I. Frigerio and P. Pederzoli",
year = "1999",
month = "9",
language = "Italian",
volume = "51",
pages = "359--366",
journal = "Chirurgia Italiana",
issn = "0009-4773",
publisher = "Bi & Gi Editori",
number = "5",

}

TY - JOUR

T1 - Valutazione della qualità della vita nel carcinoma pancreatico

T2 - risultati di uno studio multicentrico europeo.

AU - Bassi, C.

AU - Johnson, C.

AU - Fitzsimmons, D.

AU - Falconi, M.

AU - Butturini, G.

AU - Contro, C.

AU - Frigerio, I.

AU - Pederzoli, P.

PY - 1999/9

Y1 - 1999/9

N2 - Quality of life (Qol) assessment is a mandatory endpoint of cancer clinical trials. Little research has been conducted on pancreatic cancer (Pc) and no disease specific Qol questionnaire exists. We report on the development of the European Organization for Research and Treatment of Cancer (EORTC) Pc Qol module to supplement the core cancer module (QLQ-C30). Literature research and qualitative interviews with 6 specialists and 34 patients in the UK were followed by construction of a questionnaire, a peer review by international specialists and EORTC. Administration of the QLQ-C 30, a provisional Pc module and a qualitative debriefing interview was performed on 78 patients in 8 countries stratified into groups by disease stage and treatment intention. Pretesting identified that 23/26 questions had an adequate internal reliability (Cronbach's alpha > 0.7) and construct validity (Pearson's r 0.4-0.6). The median time of completion was 12 mins. Qualitative analysis indicates that the module is easy to complete and cross culturally applicable. The EORTC QLO-PAN 26 includes 26 items covering symptoms, body image, sexuality and the emotional and social consequences of Pc. It is intended for use in patients undergoing clinical trials for pancreatic cancer including surgery, chemotherapy and radiotherapy and will allow the detection of small but clinically meaningful differences in clinical trials for Pc.

AB - Quality of life (Qol) assessment is a mandatory endpoint of cancer clinical trials. Little research has been conducted on pancreatic cancer (Pc) and no disease specific Qol questionnaire exists. We report on the development of the European Organization for Research and Treatment of Cancer (EORTC) Pc Qol module to supplement the core cancer module (QLQ-C30). Literature research and qualitative interviews with 6 specialists and 34 patients in the UK were followed by construction of a questionnaire, a peer review by international specialists and EORTC. Administration of the QLQ-C 30, a provisional Pc module and a qualitative debriefing interview was performed on 78 patients in 8 countries stratified into groups by disease stage and treatment intention. Pretesting identified that 23/26 questions had an adequate internal reliability (Cronbach's alpha > 0.7) and construct validity (Pearson's r 0.4-0.6). The median time of completion was 12 mins. Qualitative analysis indicates that the module is easy to complete and cross culturally applicable. The EORTC QLO-PAN 26 includes 26 items covering symptoms, body image, sexuality and the emotional and social consequences of Pc. It is intended for use in patients undergoing clinical trials for pancreatic cancer including surgery, chemotherapy and radiotherapy and will allow the detection of small but clinically meaningful differences in clinical trials for Pc.

UR - http://www.scopus.com/inward/record.url?scp=0033187470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033187470&partnerID=8YFLogxK

M3 - Articolo

C2 - 10738609

AN - SCOPUS:0033187470

VL - 51

SP - 359

EP - 366

JO - Chirurgia Italiana

JF - Chirurgia Italiana

SN - 0009-4773

IS - 5

ER -